ライフサイエンスコーパス: Cryptococcus

1 rine infection for the human fungal pathogen Cryptococcus.

2 n >10% of patients with KS, tuberculosis, or Cryptococcus.

3 orphotype required for sexual development in Cryptococcus.

4 o have in-vitro and in-vivo activity against cryptococcus.

5 , 16% (4/25) for tuberculosis, 14% (1/7) for Cryptococcus, 10% (1/10) for Mycobacterium avium complex

6 Western blot analysis showed that Cryptococcus also induces phosphorylation of focal adhes

7 Cryptococcus amylolentus is the most closely known relat

8 Invasive fungal diseases (IFD) caused by Cryptococcus and dimorphic fungi are associated with sig

9 and treatment of cerebral infections (e.g., Cryptococcus and Plasmodium).

10 cally relevant organisms, including Candida, Cryptococcus, and Aspergillus, in subjects with increasi

11 e host defense against Candida, Aspergillus, Cryptococcus, and others, with specific elements of the

12 Detection of Cryptococcus antigen (CrAg) is invaluable for establishi

13 ansmissions; and prevention and treatment of Cryptococcus-associated immune reconstitution syndrome.

14 e for the exploration of the relationship in Cryptococcus between cellular morphology and pathogenesi

15 Previous studies have demonstrated that Cryptococcus binding and invasion of human brain microva

16 ciated with host immune response rather than Cryptococcus burden.

17 Cryptococcus can cause meningoencephalitis (CM) among pr

18 of fungal antigens in body fluids, including cryptococcus capsular polysaccharide, histoplasma antige

19 Cryptococcus cells encounter high copper levels in the l

20 in repetitive elements predicted to comprise Cryptococcus centromeres.

21 e aspirate of the chest lesions demonstrated Cryptococcus coinfection.

22 the recruitment of AIC components to nascent Cryptococcus-containing vacuoles (CnCVs) regulates the i

23 Cryptococcus contains more than 50 genes sharing high se

24 Here we demonstrate that two Cryptococcus copper transporters, Ctr1 and Ctr4, differe

25 Pichia angusta VKM Y-2559 and the oleaginous Cryptococcus curvatus VKM Y-3288 yeast cells were immobi

26 me resequencing of the human fungal pathogen Cryptococcus deuterogattii identified an outbreak lineag

27 Cryptococcus gattii (Cg) infection emerged in British Co

28 Cryptococcus gattii and Cryptococcus neoformans are caus

29 Cryptococcus neoformans and Cryptococcus gattii are closely related pathogenic fungi

30 Cryptococcus neoformans and Cryptococcus gattii are closely related pathogenic fungi

31 he prediction of Cryptococcus neoformans and Cryptococcus gattii in Europe is an important tool to un

32 Longer-term morbidity and outcomes of Cryptococcus gattii infection are not described.

33 erapy and management of complications due to Cryptococcus gattii infection in 86 Australian patients

34 Cryptococcus gattii is an emerging fungal pathogen on th

35 Cryptococcus gattii is an emerging intracellular pathoge

36 Cryptococcus gattii is responsible for a large outbreak

37 es of strains of Cryptococcus neoformans and Cryptococcus gattii isolated from serial episodes of cry

38 lecular types of the Cryptococcus neoformans/Cryptococcus gattii species complex that infect dogs and

39 athway for virulence of the pathogenic yeast Cryptococcus gattii using the highly virulent Vancouver

40 lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in

41 la-zoster virus, and Cryptococcus neoformans/Cryptococcus gattii We describe a multicenter evaluation

42 Cryptococcus gattii, an emerging fungal pathogen in the

43 bout the virulence of the molecular types in Cryptococcus gattii.

44 fungal species: Cryptococcus neoformans and Cryptococcus gattii.

45 isease caused by Cryptococcus neoformans and Cryptococcus gattii.

46 ccharomyces GAL clusters and coexists in the Cryptococcus genome with unclustered GAL paralogs.

47 Heterologous expression of Cryptococcus HXS1 rendered the S. cerevisiae mutant lack

48 Fungal and bacteriological studies showed Cryptococcus in 64 (19.5%) patients, pneumococcus in 8 (

49 Rho pulldown assays revealed that Cryptococcus induces activation of three members of RhoG

50 accumulation of CD11b(+) DC in the lungs of Cryptococcus-infected mice is primarily attributable to

51 Fungal culture or histopathology confirmed Cryptococcus infection for 20 patients (52.6%), and CrAg

52 Patient outcome following Cryptococcus infection is linked to initial fungal burde

53 hoproteomic analysis of the host response to Cryptococcus infection.

54 Cryptococcus is a major fungal pathogen that frequently

55 Cryptococcus is an emerging global health threat that is

56 Cryptococcus is the most common cause of adult meningiti

57 Cryptococcus is the most common cause of meningitis in a

58 Znf2, a master regulator of morphogenesis in Cryptococcus, is necessary and sufficient for the produc

59 Cryptococcus isolates from 15 dogs and 27 cats were type

60 th molecular type, but the susceptibility of Cryptococcus isolates from dogs and cats is largely unkn

61 nsistent with the role of Fbp1 in regulating Cryptococcus-macrophage interaction and fungal virulence

62 llular proliferation after phagocytosis in a Cryptococcus-macrophage interaction assay, which likely

63 tory blood immune signature, possibly due to Cryptococcus modulation of the host immune response.

64 erable genetic diversity compared with other Cryptococcus molecular types and could be divided into t

65 nfected with a moderately virulent strain of Cryptococcus neoformans (52D), which resulted in prolong

66 Cryptococcus neoformans (Cn) is a common facultative int

67 Cryptococcus neoformans (Cn) is a deadly fungal pathogen

68 iodiomycete forming an induced DOPA-melanin, Cryptococcus neoformans (CN); and the slow-growing envir

69 ith Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma ca

70 Isavuconazole showed good activities against Cryptococcus neoformans (MIC90, 0.12 mug/ml) and other n

71 s presenting with P. marneffei (n = 719) and Cryptococcus neoformans (n = 1598) infection to the Hosp

72 Cryptococcus neoformans admissions were not seasonal, an

73 es for melanization of the pathogenic fungus Cryptococcus neoformans also offers unique opportunities

74 the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp.

75 Aspergillus fumigatus, Alternaria alternata, Cryptococcus neoformans and Candida albicans) proteins w

76 e of macrophage autophagy in the response to Cryptococcus neoformans and Candida albicans, two import

77 nse against two prototypic fungal pathogens, Cryptococcus neoformans and Candida albicans.

78 Cryptococcus neoformans and Cryptococcus gattii are clos

79 Cryptococcus neoformans and Cryptococcus gattii are clos

80 Fundamental niche prediction of Cryptococcus neoformans and Cryptococcus gattii in Europ

81 ompare the molecular genotypes of strains of Cryptococcus neoformans and Cryptococcus gattii isolated

82 marily caused by two related fungal species: Cryptococcus neoformans and Cryptococcus gattii.

83 Cryptococcosis is a fungal disease caused by Cryptococcus neoformans and Cryptococcus gattii.

84 rabidopsis thaliana, Caenorhabditis elegans, Cryptococcus neoformans and Drosophila melanogaster.

85 erol endoperoxide, which were active against Cryptococcus neoformans and methicillin-resistance Staph

86 +) channel present in the plasma membrane of Cryptococcus neoformans and other fungi.

87 in GM-CSF are susceptible to infections with Cryptococcus neoformans and other opportunistic fungi.

88 Cryptococcus gattii and Cryptococcus neoformans are causal agents of cryptococco

89 gh activity toward Aspergillus fumigatus and Cryptococcus neoformans at acidic pH, yet remained nonto

90 e infections with pathogenic species such as Cryptococcus neoformans Because the purine biosynthesis

91 Infection with Cryptococcus neoformans begins when desiccated yeast cel

92 se, and catalytically dead Tps2PD(D24N) from Cryptococcus neoformans bound to trehalose-6-phosphate (

93 ved (Blastomyces dermatitidis by culture and Cryptococcus neoformans by PLEX-ID).

94 Upon ingestion by macrophages, Cryptococcus neoformans can survive and replicate intrac

95 ificity of V region-identical IgE and IgA to Cryptococcus neoformans capsular polysaccharide and foun

96 Cryptococcus neoformans capsular polysaccharides glucuro

97 Cryptococcus neoformans causes life-threatening meningit

98 Cryptococcus neoformans causes life-threatening meningoe

99 xin, Srx1, in oxidative stress resistance of Cryptococcus neoformans causing fungal meningoencephalit

100 The role of B cells in resistance to Cryptococcus neoformans disease (i.e., cryptococcosis) i

101 aride capsule of the human pathogenic fungus Cryptococcus neoformans elicit diverse effects on fungal

102 The human fungal pathogen Cryptococcus neoformans encodes many Cu-responsive genes

103 The immune response to Cryptococcus neoformans following pulmonary infection of

104 Cryptococcus neoformans frequently causes fungal meningi

105 e expulsion of the lethal endosomal pathogen Cryptococcus neoformans from mammalian macrophages, also

106 Eumelanins produced by pathogenic Cryptococcus neoformans fungi are virulence factors that

107 ed the role of a Th2 bias in pathogenesis of Cryptococcus neoformans H99 infection by comparing inhal

108 The human pathogenic fungus Cryptococcus neoformans has a distinctive polysaccharide

109 The human pathogenic fungus Cryptococcus neoformans has a large polysaccharide capsu

110 Furthermore, Cryptococcus neoformans has become a primary human patho

111 The fungus Cryptococcus neoformans has emerged as a major cause of

112 nistic fungal pathogens Candida albicans and Cryptococcus neoformans However, the molecular mechanism

113 e mAbs to the capsule of the fungal pathogen Cryptococcus neoformans impaired yeast budding by trappi

114 Persistent pulmonary infection with Cryptococcus neoformans in C57BL/6 mice results in chron

115 The burden of Cryptococcus neoformans in cerebrospinal fluid (CSF) pre

116 he development of the protective response to Cryptococcus neoformans in mice with cryptococcal pneumo

117 Experimental pulmonary Cryptococcus neoformans infection in BALB/c mice is asso

118 tes transmigration of the neurotropic fungus Cryptococcus neoformans into the brain parenchyma after

119 The mechanisms by which Cryptococcus neoformans invades the brain are largely un

120 The mechanism by which Cryptococcus neoformans invades the central nervous syst

121 Cryptococcus neoformans is a basidiomycete fungus that i

122 The fungal meningitis pathogen Cryptococcus neoformans is a central driver of mortality

123 The encapsulated fungus Cryptococcus neoformans is a common cause of life-threat

124 Lethal disease caused by the fungus Cryptococcus neoformans is a consequence of the combined

125 Cryptococcus neoformans is a facultative intracellular f

126 Cryptococcus neoformans is a facultative intracellular o

127 Cryptococcus neoformans is a facultative intracellular p

128 Cryptococcus neoformans is a fatal fungal pathogen of hu

129 Cryptococcus neoformans is a fungal pathogen causing pul

130 Cryptococcus neoformans is a fungal pathogen that causes

131 Cryptococcus neoformans is a fungal pathogen that causes

132 Cryptococcus neoformans is a fungal pathogen that causes

133 Cryptococcus neoformans is a fungal pathogen that encoun

134 Cryptococcus neoformans is a fungal pathogen with a uniq

135 Cryptococcus neoformans is a fungal pathogen with worldw

136 Cryptococcus neoformans is a human fungal pathogen that

137 Cryptococcus neoformans is a human fungal pathogen that

138 Cryptococcus neoformans is a human fungal pathogen that

139 The basidiomycete fungus Cryptococcus neoformans is a leading cause of AIDS-relat

140 Cryptococcus neoformans is a neurotropic fungal pathogen

141 Cryptococcus neoformans is a pathogenic fungus responsib

142 Cryptococcus neoformans is a pathogenic yeast that can i

143 Cryptococcus neoformans is a significant fungal pathogen

144 Cryptococcus neoformans is a ubiquitous, opportunistic f

145 Cryptococcus neoformans is an encapsulated fungal pathog

146 Cryptococcus neoformans is an encapsulated human-pathoge

147 Cryptococcus neoformans is an important human, fungal pa

148 Cryptococcus neoformans is an opportunistic fungal patho

149 Cryptococcus neoformans is an opportunistic fungal patho

150 Cryptococcus neoformans is an opportunistic fungal patho

151 Cryptococcus neoformans is an opportunistic fungal patho

152 Cryptococcus neoformans is an opportunistic fungal patho

153 Cryptococcus neoformans is an opportunistic fungal patho

154 Cryptococcus neoformans is an opportunistic human pathog

155 Cryptococcus neoformans is an opportunistic pulmonary fu

156 Cryptococcus neoformans is an unconventional dimorphic f

157 ity to progressive infection with the fungus Cryptococcus neoformans is associated with an allergic p

158 pulmonary infection with the fungal pathogen Cryptococcus neoformans is associated with the accumulat

159 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans is associated with the CCR2-medi

160 The fungus Cryptococcus neoformans is currently the fourth greatest

161 Cryptococcus neoformans is ecologically widespread and a

162 the disease (cryptococcal disease) caused by Cryptococcus neoformans is incontrovertible, but whether

163 The opportunistic yeast Cryptococcus neoformans is surrounded by a polysaccharid

164 Cryptococcus neoformans is the leading cause of death by

165 Cryptococcus neoformans is the most common cause of adul

166 Cryptococcus neoformans is the only encapsulated human-p

167 The manifestation of virulence traits in Cryptococcus neoformans is thought to rely on intracellu

168 9%) Candida tropicalis isolates and 1 (2.4%) Cryptococcus neoformans isolate.

169 andida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infe

170 es, 15 isolates of the Zygomycetes order, 10 Cryptococcus neoformans isolates, 8 Rhodotorula isolates

171 C. glabrata, and 53 C. krusei isolates), 35 Cryptococcus neoformans isolates, and 191 other clinical

172 Numerous virulence factors expressed by Cryptococcus neoformans modulate host defenses by promot

173 rable to infection by the encapsulated yeast Cryptococcus neoformans Most commonly found in the envir

174 The pathogenic fungus Cryptococcus neoformans must adapt to glucose-limited co

175 The pathogenic fungus Cryptococcus neoformans must overcome multiple stressors

176 of 1201 signature-tagged deletion strains of Cryptococcus neoformans mutants to identify previously u

177 The Cryptococcus neoformans polysaccharide capsule is a well

178 xylomannan (GXM), the major component of the Cryptococcus neoformans polysaccharide capsule, hydrolyz

179 The pathogenic fungus Cryptococcus neoformans produces PGE2, and we found that

180 aride capsule of the human pathogenic fungus Cryptococcus neoformans promotes opsonization but also i

181 ulmonary clearance of the encapsulated yeast Cryptococcus neoformans requires a T1 adaptive immune re

182 The basidiomycete fungal pathogen Cryptococcus neoformans requires the PUF protein, Pum1,

183 Structurally, the Cryptococcus neoformans Sp1 (Cn Sp1) protein was found t

184 of C57BL/6 mice with the moderately virulent Cryptococcus neoformans strain 52D models the complex ad

185 murine model of C57BL/6J mice infected with Cryptococcus neoformans strain 52D.

186 ential of these genes by comparing wild-type Cryptococcus neoformans strain H99 with deletant and com

187 of interferon-gamma transgene expression by Cryptococcus neoformans strain H99gamma in abrogating al

188 oducibility strains (4 Candida species and 6 Cryptococcus neoformans strains), and 746 isolates of Ca

189 otective immune responses to highly virulent Cryptococcus neoformans strains, such as H99, are associ

190 In order for Cryptococcus neoformans to invade the central nervous sy

191 ability of the opportunistic fungal pathogen Cryptococcus neoformans to resist oxidative stress is on

192 ignalling pathways to the basal tolerance of Cryptococcus neoformans towards fluconazole, the widely

193 Cryptococcus neoformans typically grows in a yeast-like

194 Most cases of cryptococcosis are caused by Cryptococcus neoformans var. grubii (serotype A), which

195 Cryptococcus neoformans var. grubii is the causative age

196 Compared to other well-studied Cryptococcus neoformans virulence factors such as the po

197 Cryptococcus neoformans was first described as a human f

198 ns, Candida krusei, Candida parapsilosis and Cryptococcus neoformans were investigated.

199 f a human pathogen and basidiomycetous yeast Cryptococcus neoformans were investigated.

200 ave directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infecte

201 ) exhibit potent antifungal activity against Cryptococcus neoformans with high selectivity.

202 of lipid droplets during the interaction of Cryptococcus neoformans with macrophages in the presence

203 vestigated the outcome of the interaction of Cryptococcus neoformans with murine macrophages using la

204 rcular (Histoplasma capsulatum) to punctate (Cryptococcus neoformans) to labeling at the bud sites (C

205 a spp., 146 from 9 Aspergillus spp., 84 from Cryptococcus neoformans, 40 from 23 other mold species,

206 trophils have been shown to efficiently kill Cryptococcus neoformans, a causative agent of meningoenc

207 Human infection with Cryptococcus neoformans, a common fungal pathogen, follo

208 This is particularly true for Cryptococcus neoformans, a human fungal pathogen that ca

209 Here, we demonstrate that Cryptococcus neoformans, a model eukaryotic pathogen, re

210 One such organism is Cryptococcus neoformans, a pathogenic yeast that causes

211 It has shown potent activity against Cryptococcus neoformans, a yeast that can affect immunoc

212 The fungal pathogens Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus have

213 sential for virulence of the fungal pathogen Cryptococcus neoformans, and bacterial P5CDHs have been

214 hly active against a second fungal pathogen, Cryptococcus neoformans, and moderately active against a

215 can is a major component of the cell wall of Cryptococcus neoformans, but its function has not been i

216 As in Cryptococcus neoformans, cellular trehalose was reduced

217 n of clinically significant Candida species, Cryptococcus neoformans, Histoplasma capsulatum, and Bla

218 hannel from the model human fungal pathogen, Cryptococcus neoformans, is directly activated by the de

219 mune response against the pathogenic fungus, Cryptococcus neoformans, is unknown.

220 Compared to Cryptococcus neoformans, little is known about the virul

221 e fungal pathogens Aspergillus fumigatus and Cryptococcus neoformans, little was known about their in

222 Pathogens included Balamuthia mandrillaris, Cryptococcus neoformans, lymphocytic choriomeningitis vi

223 In the pathogenic fungus Cryptococcus neoformans, noncanonical Gbeta Gib2 promote

224 Urease, a major virulence factor for Cryptococcus neoformans, promotes lethal meningitis/ence

225 The cell wall of pathogenic fungi such as Cryptococcus neoformans, provides a formidable barrier t

226 on and analysis of SRP in the human pathogen Cryptococcus neoformans, providing the first description

227 he major human opportunistic fungal pathogen Cryptococcus neoformans, remains unknown.

228 Candida albicans, Aspergillus fumigatus and Cryptococcus neoformans, result in more deaths annually

229 In Cryptococcus neoformans, sexual reproduction occurs thro

230 Cryptococcus neoformans, the causative agent of cryptoco

231 pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage organism Zygo

232 In the human fungal pathogen Cryptococcus neoformans, the homeodomain transcription f

233 Cryptococcus neoformans, the predominant etiological age

234 In the human fungal pathogen Cryptococcus neoformans, the Rim101 protein retains cons

235 In the human fungal pathogen Cryptococcus neoformans, the SREBP orthologue Sre1 is im

236 Using the yeast Cryptococcus neoformans, we describe a mechanism by whic

237 r understanding Ab-mediated immunity against Cryptococcus neoformans, where the different isotypes ma

238 sis is important for virulence of the fungus Cryptococcus neoformans, which can cause lethal meningoe

239 ypic diversity in the human pathogenic yeast Cryptococcus neoformans, which is globally distributed a

240 D82 showed rapid and specific recruitment to Cryptococcus neoformans-containing phagosomes compared t

241 However, it is not known if Cryptococcus neoformans-induced changes in lung function

242 nown whether such an association exists with Cryptococcus neoformans.

243 Candida species, Aspergillus fumigatus, and Cryptococcus neoformans.

244 for virulence of the human pathogenic fungus Cryptococcus neoformans.

245 th a similar function in the related species Cryptococcus neoformans.

246 mall-RNA biogenesis in the pathogenic fungus Cryptococcus neoformans.

247 ual development of the human fungal pathogen Cryptococcus neoformans.

248 ntainment following pulmonary challenge with Cryptococcus neoformans.

249 C57BL/6 mice after pulmonary infection with Cryptococcus neoformans.

250 hose for the pathogens, Candida albicans and Cryptococcus neoformans.

251 involved in polysaccharide O-acetylation in Cryptococcus neoformans.

252 haromyces cerevisiae, Malassezia furfur, and Cryptococcus neoformans.

253 illness caused by the opportunistic pathogen Cryptococcus neoformans.

254 ts (MC) arising from phenotypic switching of Cryptococcus neoformans.

255 transgene array in the human fungal pathogen Cryptococcus neoformans.

256 prolongs the survival of mice infected with Cryptococcus neoformans.

257 ghest prevalence of coinfection with HIV and Cryptococcus neoformans.

258 e host survival of the human fungal pathogen Cryptococcus neoformans.

259 sponse to infection with the fungal pathogen Cryptococcus neoformans.

260 nsing pathway in the human pathogenic fungus Cryptococcus neoformans.

261 t regulates virulence in the fungal pathogen Cryptococcus neoformans.

262 IP5/IP7, which is essential for virulence of Cryptococcus neoformans.

263 central role in regulating the virulence of Cryptococcus neoformans.

264 d with the distantly related fungal pathogen Cryptococcus neoformans.

265 of H3K27 methylation (H3K27me) in the yeast Cryptococcus neoformans.

266 Molecular types of the Cryptococcus neoformans/Cryptococcus gattii species comp

267 an parechovirus, varicella-zoster virus, and Cryptococcus neoformans/Cryptococcus gattii We describe

268 ction with the opportunistic fungal pathogen Cryptococcus neoformans; however, the role of plasmacyto

269 genes in bacteria [16], and mating events in Cryptococcus neoformans[14, 17].

270 molecule and the preferred carbon source for Cryptococcus, plays a critical role in fungal developmen

271 h from infection (including tuberculosis and cryptococcus) shortly after the initiation of antiretrov

272 MICs varied with Cryptococcus species and molecular type in dogs and cats

273 Cryptococcus species are known agents of opportunistic i

274 We evaluated Cryptococcus species as a cause of acute respiratory inf

275 Species within the human pathogenic Cryptococcus species complex are major threats to public

276 sely known related species of the pathogenic Cryptococcus species complex, and it is non-pathogenic.

277 Additionally, while pathogenic Cryptococcus species have bipolar mating systems with a

278 The yeast genera Kondoa might be protective; Cryptococcus species might also affect asthma severity.

279 etween C. amylolentus and related pathogenic Cryptococcus species provide evidence that multiple chro

280 Cryptococcus species were the most common pathogens dete

281 to bipolar mating systems in the pathogenic Cryptococcus species, as well as its possible link with

282 led that, similar to those of the pathogenic Cryptococcus species, C. amylolentus has regional centro

283 nitiated for Saccharomyces, Aspergillus, and Cryptococcus species, remain to be determined.

284 T locus that is now extant in the pathogenic Cryptococcus species.

285 g peptide-MHC class II molecules to identify Cryptococcus-specific Treg cells combined with genetic f

286 age-gated K(v) channel subunits are found in Cryptococcus spp.

287 ght patients received ISAV for IFD caused by Cryptococcus spp. (n = 9), Paracoccidioides spp. (n = 10

288 Cryptococcus spp. cause fungal meningitis, a life-threat

289 The genomes of Aspergillus spp. and Cryptococcus spp., but not those of S. cerevisiae or the

290 he Madison Chamber during exposure can alter Cryptococcus survival and dose retained in mice.

291 cerebrospinal fluid (CSF) clearance rate of cryptococcus, termed early fungicidal activity, measured

292 transporter-like proteins (Hxs1 and Hxs2) in Cryptococcus that share the highest sequence identity wi

293 Upon pulmonary infection with Cryptococcus, Treg cells accumulated in the lung parench

294 Here we describe the first case of Cryptococcus uzbekistanensis causing bone marrow infecti

295 rationale to support continued investment in Cryptococcus vaccine research, potential challenges that

296 hat an F-box protein, Fbp1, is essential for Cryptococcus virulence independent of the classical viru

297 transporters is induced and is critical for Cryptococcus virulence.

298 of the peripheral CD4(+) T-cell response to Cryptococcus was associated with disease severity and ou

299 In contrast, the GAL cluster of Cryptococcus yeasts was assembled independently from the

300 nce procedures exist for Candida species and Cryptococcus yeasts; however, no standardized methods ha